That hardly fits with The New York Times’ reputation of producing a solid, fair investigative piece,” Barbier wrote. The Times article raised concerns over the veracity of papers authored by H.Y. Barbier also claimed the Times reporter interviewed several researchers who were highly critical of the Cassava data regarding simufilam. Like The New York Times, we observe standards that govern our dealings with critics and colleagues alike. We only wish The New York Times reporter had treated us the same way,” Barbier said.

Source: New York Times April 28, 2022 01:28 UTC